铂化疗-话题@MedSci

#铂化疗#

25篇内容 | 934人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1490088, encodeId=b30f14900889f, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=中国之声：首个国产PD-1抑制剂联合双铂化疗新辅助治疗IIB-IIIB期NSCLC安全有效！| WCLC 2022速递, objectType=article, longId=735667, objectId=7b4ee35667af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b4ee35667af, replyNumber=0, likeNumber=40, createdTime=2022-08-13, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b4ee35667af, moduleTitle=中国之声：首个国产PD-1抑制剂联合双铂化疗新辅助治疗IIB-IIIB期NSCLC安全有效！| WCLC 2022速递, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b4ee35667af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490086, encodeId=80a614900868c, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=Lancet Oncol：纳武单抗联合奥沙利铂化疗一线治疗晚期或复发性胃或胃食管交界癌, objectType=article, longId=295669, objectId=d4cf2956690e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4cf2956690e, replyNumber=0, likeNumber=22, createdTime=2022-02-16, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4cf2956690e, moduleTitle=Lancet Oncol：纳武单抗联合奥沙利铂化疗一线治疗晚期或复发性胃或胃食管交界癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4cf2956690e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490087, encodeId=17ac149008e71, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=Lancet Oncol：Sugemalimab联合含铂化疗一线治疗转移性非小细胞肺癌, objectType=article, longId=295668, objectId=63ef2956689c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63ef2956689c, replyNumber=0, likeNumber=41, createdTime=2022-02-16, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63ef2956689c, moduleTitle=Lancet Oncol：Sugemalimab联合含铂化疗一线治疗转移性非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63ef2956689c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490085, encodeId=b543149008556, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=Cancer：儿童铂化疗后的听力损失发病率调查, objectType=article, longId=217568, objectId=b0b921e568a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0b921e568a8, replyNumber=0, likeNumber=31, createdTime=2021-09-25, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0b921e568a8, moduleTitle=Cancer：儿童铂化疗后的听力损失发病率调查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0b921e568a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490084, encodeId=8ab1149008401, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=Nat Med：Toripalimab联合吉西他滨-顺铂化疗治疗晚期鼻咽癌的3期临床研究, objectType=article, longId=215448, objectId=f2db21544877, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2db21544877, replyNumber=0, likeNumber=34, createdTime=2021-08-09, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2db21544877, moduleTitle=Nat Med：Toripalimab联合吉西他滨-顺铂化疗治疗晚期鼻咽癌的3期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2db21544877)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490083, encodeId=a0c414900835b, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=Eur Arch Otorhinolaryngol：顺铂化疗对内耳功能和血清prestin浓度的影响 , objectType=article, longId=214397, objectId=df2021439e7e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df2021439e7e, replyNumber=0, likeNumber=34, createdTime=2021-07-20, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df2021439e7e, moduleTitle=Eur Arch Otorhinolaryngol：顺铂化疗对内耳功能和血清prestin浓度的影响 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df2021439e7e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490082, encodeId=d3f71490082d0, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=武田呈报Mobocertinib治疗先前接受过含铂化疗的EGFR外显子20插入+ mNSCLC患者的阳性结果, objectType=article, longId=206667, objectId=b05220666ed0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b05220666ed0, replyNumber=0, likeNumber=42, createdTime=2021-02-04, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b05220666ed0, moduleTitle=武田呈报Mobocertinib治疗先前接受过含铂化疗的EGFR外显子20插入+ mNSCLC患者的阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b05220666ed0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490081, encodeId=fda214900813b, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=BRCA1/2突变铂敏感型复发性卵巢癌：奥拉帕利较非铂化疗能有效改善PFS, objectType=article, longId=206058, objectId=87ad20605893, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87ad20605893, replyNumber=0, likeNumber=28, createdTime=2021-01-24, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87ad20605893, moduleTitle=BRCA1/2突变铂敏感型复发性卵巢癌：奥拉帕利较非铂化疗能有效改善PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87ad20605893)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490080, encodeId=9c48149008000, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关, objectType=article, longId=199985, objectId=72b119998516, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72b119998516, replyNumber=0, likeNumber=43, createdTime=2020-08-29, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72b119998516, moduleTitle=Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72b119998516)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490079, encodeId=ec4614900e928, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=J Clin Oncol：吉非替尼VS吉非替尼加培美曲塞和卡铂化疗在EGFR突变肺癌中的对比分析, objectType=article, longId=198499, objectId=8e7819849955, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e7819849955, replyNumber=0, likeNumber=29, createdTime=2020-08-02, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e7819849955, moduleTitle=J Clin Oncol：吉非替尼VS吉非替尼加培美曲塞和卡铂化疗在EGFR突变肺癌中的对比分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e7819849955)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490078, encodeId=726314900e8d2, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=Lancet：Atezolizumab联合铂化疗一线治疗转移性尿路上皮癌, objectType=article, longId=194245, objectId=b6fe19424555, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6fe19424555, replyNumber=0, likeNumber=27, createdTime=2020-05-17, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6fe19424555, moduleTitle=Lancet：Atezolizumab联合铂化疗一线治疗转移性尿路上皮癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6fe19424555)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490077, encodeId=48c914900e794, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=Lancet:吉西他滨-铂化疗用于晚期上尿路上皮癌的局部治疗, objectType=article, longId=189914, objectId=531c18991483, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=531c18991483, replyNumber=0, likeNumber=40, createdTime=2020-03-14, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=531c18991483, moduleTitle=Lancet:吉西他滨-铂化疗用于晚期上尿路上皮癌的局部治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=531c18991483)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490076, encodeId=84b714900e69d, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=Cell Death Dis：维生素D可增强口腔鳞状细胞癌对顺铂化疗的敏感性！, objectType=article, longId=186148, objectId=4cea18614876, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cea18614876, replyNumber=0, likeNumber=39, createdTime=2020-01-14, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cea18614876, moduleTitle=Cell Death Dis：维生素D可增强口腔鳞状细胞癌对顺铂化疗的敏感性！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cea18614876)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490075, encodeId=7f3714900e514, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=Lancet Oncol：5mg奥氮平联合标准止吐方案用于顺铂化疗患者的止吐, objectType=article, longId=184675, objectId=c4cf1846e59f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4cf1846e59f, replyNumber=0, likeNumber=31, createdTime=2019-12-14, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4cf1846e59f, moduleTitle=Lancet Oncol：5mg奥氮平联合标准止吐方案用于顺铂化疗患者的止吐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4cf1846e59f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490074, encodeId=df5114900e4dc, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=JAMA Otolaryngol Head Neck Surg：头颈癌患者放疗和顺铂化疗后听力损失预测研究, objectType=article, longId=184098, objectId=6cc8184098d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cc8184098d1, replyNumber=0, likeNumber=25, createdTime=2019-12-05, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cc8184098d1, moduleTitle=JAMA Otolaryngol Head Neck Surg：头颈癌患者放疗和顺铂化疗后听力损失预测研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cc8184098d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490073, encodeId=240f14900e35e, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=Sci Rep：肿瘤浸润性淋巴细胞对患有转移性尿路上皮癌且接受铂化疗患者的预后影响, objectType=article, longId=138562, objectId=74ad138562ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74ad138562ae, replyNumber=0, likeNumber=22, createdTime=2018-05-20, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74ad138562ae, moduleTitle=Sci Rep：肿瘤浸润性淋巴细胞对患有转移性尿路上皮癌且接受铂化疗患者的预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74ad138562ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490072, encodeId=6a7c14900e222, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=J Clin Periodontol：顺铂化疗对钛种植体周围骨修复的影响, objectType=article, longId=130292, objectId=2a04130292b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a04130292b0, replyNumber=0, likeNumber=24, createdTime=2018-02-24, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a04130292b0, moduleTitle=J Clin Periodontol：顺铂化疗对钛种植体周围骨修复的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a04130292b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490071, encodeId=2b4314900e18d, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=Acta Oncol：睾丸癌幸存者铂化疗前后听力损失研究, objectType=article, longId=130213, objectId=128f1302133b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=128f1302133b, replyNumber=0, likeNumber=30, createdTime=2018-02-20, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=128f1302133b, moduleTitle=Acta Oncol：睾丸癌幸存者铂化疗前后听力损失研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=128f1302133b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490070, encodeId=039814900e03f, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=Lancet oncol：多西他赛、卡铂化疗，联合曲妥珠单抗和帕托珠单抗治疗HER2阳性乳腺癌患者的疗效与副反应。, objectType=article, longId=121373, objectId=6a6c1213e360, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a6c1213e360, replyNumber=0, likeNumber=30, createdTime=2017-11-27, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a6c1213e360, moduleTitle=Lancet oncol：多西他赛、卡铂化疗，联合曲妥珠单抗和帕托珠单抗治疗HER2阳性乳腺癌患者的疗效与副反应。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a6c1213e360)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490069, encodeId=60411490069b0, content=<a href='/topic/show?id=bf08965e9a7' target=_blank style='color:#2F92EE;'>#铂化疗#</a>, objectTitle=Lancet oncol：派姆单抗用于不能用顺铂化疗的晚期尿路上皮肿瘤患者的疗效和安全性。, objectType=article, longId=114396, objectId=95c311439626, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95c311439626, replyNumber=0, likeNumber=32, createdTime=2017-09-28, rootId=0, userName=drj2006, userId=67238689175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95c311439626, moduleTitle=Lancet oncol：派姆单抗用于不能用顺铂化疗的晚期尿路上皮肿瘤患者的疗效和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95c311439626)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

铂化疗

2020-05-29

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

中国之声：首个国产PD-1抑制剂联合双铂化疗新辅助治疗IIB-IIIB期NSCLC安全有效！| WCLC 2022速递

2022-08-13

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

Lancet Oncol：纳武单抗联合奥沙利铂化疗一线治疗晚期或复发性胃或胃食管交界癌

2022-02-16

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

Lancet Oncol：Sugemalimab联合含铂化疗一线治疗转移性非小细胞肺癌

2022-02-16

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

Cancer：儿童铂化疗后的听力损失发病率调查

2021-09-25

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

Nat Med：Toripalimab联合吉西他滨-顺铂化疗治疗晚期鼻咽癌的3期临床研究

2021-08-09

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

Eur Arch Otorhinolaryngol：顺铂化疗对内耳功能和血清prestin浓度的影响

2021-07-20

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

武田呈报Mobocertinib治疗先前接受过含铂化疗的EGFR外显子20插入+ mNSCLC患者的阳性结果

2021-02-04

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

BRCA1/2突变铂敏感型复发性卵巢癌：奥拉帕利较非铂化疗能有效改善PFS

2021-01-24

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关

2020-08-29

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

J Clin Oncol：吉非替尼VS吉非替尼加培美曲塞和卡铂化疗在EGFR突变肺癌中的对比分析

2020-08-02

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

Lancet：Atezolizumab联合铂化疗一线治疗转移性尿路上皮癌

2020-05-17

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

Lancet:吉西他滨-铂化疗用于晚期上尿路上皮癌的局部治疗

2020-03-14

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

Cell Death Dis：维生素D可增强口腔鳞状细胞癌对顺铂化疗的敏感性！

2020-01-14

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

Lancet Oncol：5mg奥氮平联合标准止吐方案用于顺铂化疗患者的止吐

2019-12-14

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

JAMA Otolaryngol Head Neck Surg：头颈癌患者放疗和顺铂化疗后听力损失预测研究

2019-12-05

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

Sci Rep：肿瘤浸润性淋巴细胞对患有转移性尿路上皮癌且接受铂化疗患者的预后影响

2018-05-20

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

J Clin Periodontol：顺铂化疗对钛种植体周围骨修复的影响

2018-02-24

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

Acta Oncol：睾丸癌幸存者铂化疗前后听力损失研究

2018-02-20

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

Lancet oncol：多西他赛、卡铂化疗，联合曲妥珠单抗和帕托珠单抗治疗HER2阳性乳腺癌患者的疗效与副反应。

2017-11-27

drj2006 (审核中...)

前往app查看评论内容

#铂化疗#

Lancet oncol：派姆单抗用于不能用顺铂化疗的晚期尿路上皮肿瘤患者的疗效和安全性。

2017-09-28

科室
- - 订阅+
  - 更多科室
工具
服务